Plain-English translation of NCT07175038 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , an oral medication you would take by mouth daily, to see if it can safely help people with pulmonary hypertension—a condition where blood pressure in the lungs becomes dangerously high. Researchers want to understand if this medication works alongside your current treatments and what side effects it might cause. About 40 people will participate across multiple medical centers.
High blood pressure in the lungs can make it hard to breathe and tire you out quickly, and current treatments don't work well enough for everyone. This study is exploring whether this new medication could offer another treatment option for people whose symptoms persist despite being on standard therapy.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic regularly over 24 weeks to take the medication and have your health monitored. You'll start with a 10 mg daily dose that gradually increases to 40 mg daily. During visits, doctors will perform heart catheterization procedures (a thin tube inserted into heart blood vessels to measure pressure), lung function tests, heart rhythm monitoring, and blood work to check how well the medication is working and whether you're experiencing any side effects. You continue taking your current pulmonary hypertension medications alongside the study medication throughout the trial.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States